CH EPL (R5)
1.0.1 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: 67831001

identifier: Marketing Authorisation Number/66231002

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01001107-0678310010000-0002; containedItemQuantity = 2 Pre-filled pen; description = ABRILADA Inj Lös 40 mg/0.8ml Fertpen 2 x 0.8 ml

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2020-02-12

holder: Organization Pfizer AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-Pfizer-AG

Profile: Organization

identifier: https://www.swissmedic.ch/fhir/identifier/locations/01001107, LOC Identifier/100015286, GLN Identifier/7601001010604

name: Pfizer AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products